Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
(Image Credit: AdobeStock) Inflammasome Therapeutics has completed enrollment in a multicenter phase…
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine…
(Image credit: ©peopleimages.com/AdobeStock) The Data Safety Monitoring Committee (DSMC) recently completed its…
(Image Credit: AdobeStock/Anna) Precise Bio has successfully treated a patient with PB-001,…
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
(Image Credit: AdobeStock/NVB Stocker) A recent analysis examining the effects of screen…
(Image Credit: AdobeStock/Parradee) Harrow has completed the acquisition of Melt Pharmaceuticals, which…
(Image Credit: AdobeStock) Coave Therapeutics has announced its lead gene therapy program,…
(Image Credit: AdobeStock/Ar_TH) Foundation Fighting Blindness has granted public access to de-identified…
(Image Credit: AdobeStock/Treecha) Opus Genetics has dosed the first patient in its…
Enter your email address below and subscribe to our newsletter